Robot-assisted radical prostatectomy reduced short-term complication risk by nearly half versus open surgery. Learn more from ...

Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer Completed surveys were obtained from 685 (86%) of 797 ...

At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...

No significant differences observed in standard oncologic outcomes and quality of life at 12 weeks. Robot-assisted laparoscopic prostatectomy (RALP) results in similar functional outcomes at 12 weeks ...

The use of antiplatelet and/or anticoagulant medications has increased due to irregular diets, limited physical activity, and an ...

Stereotactic body radiotherapy as salvage therapy after radical prostatectomy was well tolerated. Toxic effects were comparable to a historical cohort of patients receiving conventionally fractionated ...

Urinary incontinence (UI) after radical prostatectomy is a common and distressing complication for men with prostate cancer.

Prostate cancer is the most common malignant tumor in men, accounting for 29% of male neoplasm diagnoses in the United States alone. Radical prostatectomy remains the preferred treatment for localized ...

A TURBT allows examination beyond the bladder. Study findings support attempting nerve-sparing surgery in patients with confirmed high-risk prostate cancer. Nerve-sparing radical prostatectomy (NSRP) ...

Radical prostatectomy does not ensure a cure, with one in three men experiencing cancer recurrence and elevated PSA levels within 10 years post-surgery. Significant side effects of prostate removal ...